Lal Clinica Pesquisa E Desenvolvimento Ltda
Valinhos, São Paulo, 13270000, Brazil
NCT Number: NCT00860873
This study objective is to check the non-inferiority of the 2 formulations produced by EMS when compared with the same substances and pharmaceuticals forms of the product Condroflex (Zodiac), by promoting the relief of osteoarthrosis symptoms such as pain, stiffness and functional capacity that will be periodically measured by using the "Visual Analog Scale" of pain (VAS) and the questionnaire of Lequesne.
Looking for future studies?
Notify Me30 year–80 year
All sexes
Interventional
Phase 3
Valinhos, São Paulo, 13270000, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg
Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg
Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg
Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg
Time frame: V0 (Screening); V1 (Inclusion); V2 (2 weeks); V3 (4 weeks); V4 (8 weeks); V5 (12 weeks); V6 (24 weeks).
Azidus Brasil
Industry
Randomized Study of Two Dosage Forms (Oral Powder and Capsule) of "Chondroitin + Glucosamine Sulfate" Produced by the Laboratory EMS When Compared to the Product Condroflex (Oral Powder and Capsules) Produced by Laboratory Zodiac in the Treatment of Osteoarthrosis.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05697952
Arthritis, Joint Diseases
Seoul, South Korea
View Trial DetailsNCT02222740
Arthritis, Joint Diseases
View Trial DetailsNCT03093038
Arthritis, Joint Diseases
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT00291499
Arthritis, Joint Diseases
View Trial Details